Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Department of Respiratory Physiology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
J Robot Surg. 2023 Aug;17(4):1705-1713. doi: 10.1007/s11701-023-01578-y. Epub 2023 Mar 27.
The primary objectives of the study were to analyse the robotic approach and ultrasound-guided paravertebral block compared to thoracoscopic intercostal nerve block after robotic pulmonary lobectomy on postoperative pain and opioids use. The secondary objectives were to analyse and compare patients' necessity of additional antalgic drugs and patients' performance during respiratory therapy, following robotic surgery and in the two groups. Consecutively, 52 patients undergoing robotic pulmonary lobectomies were treated either with ropivacaine-based intercostal nerve block or paravertebral block from February 2022 to October 2022. When necessary, morphine was administered at day 1. Acetaminophen was administered as an additional antalgic drug on demand up to 3 g per day. Pain was measured 1 h after the end of the surgical procedure and daily through the pain numeric rating scale (NRS). Morphine administration rate and per day and total additional administrations of acetaminophen were recorded. Pain and opioids administration was measured 1 month after the procedure. Data were analysed in the overall population and in the intercostal nerve block group VS paravertebral block group. Overall, 34.6% of the patients required morphine administration and 51.7% of the patients required at least daily acetaminophen administration up to discharge. At 1 month postoperatively, four patients presented with chronic pain and one still was under opioid medication. At intergroup analysis, the paravertebral block group demonstrated lower NRS at fixed time points (p < 0.0001) and lower morphine consumption (45.7%VS11.8%; p = 0.02). Acetaminophen rescue administration at fixed time points was lower in the paravertebral block group (p < 0.0001) and mobility and dynamic pain resulted in better results (p = 0.03; p = 0.04). At 1 month, no differences were found between study groups. Similarly to other minimally invasive techniques, postoperative pain may arise after robotic pulmonary lobectomy. Paravertebral bloc can help to reduce postoperative pain as well as morphine and antalgic drugs administration and improve early mobilization.
本研究的主要目的是分析机器人辅助下经皮椎旁阻滞与电视胸腔镜下单侧肋间神经阻滞在机器人肺叶切除术后的镇痛效果和阿片类药物使用情况。次要目的是分析和比较两组患者在机器人手术后和术后的镇痛药物需求和呼吸治疗中的表现。2022 年 2 月至 10 月,连续 52 例行机器人肺叶切除术的患者接受罗哌卡因肋间神经阻滞或椎旁阻滞治疗。必要时,术后第 1 天给予吗啡。按需给予对乙酰氨基酚作为额外的镇痛药物,每天不超过 3g。术后 1 小时、每天通过疼痛数字评分量表(NRS)测量疼痛。记录吗啡给药率和每天及总给药次数、对乙酰氨基酚的额外给药次数。术后 1 个月评估疼痛和阿片类药物的使用情况。对全人群和肋间神经阻滞组与椎旁阻滞组进行数据分析。总体而言,34.6%的患者需要吗啡给药,51.7%的患者需要至少每天使用对乙酰氨基酚,直到出院。术后 1 个月,4 例患者出现慢性疼痛,1 例仍在使用阿片类药物。在组间分析中,椎旁阻滞组在固定时间点的 NRS 较低(p<0.0001),吗啡消耗量较低(45.7%VS11.8%;p=0.02)。椎旁阻滞组在固定时间点的对乙酰氨基酚解救给药较低(p<0.0001),活动度和动态疼痛结果更好(p=0.03;p=0.04)。术后 1 个月,两组间无差异。与其他微创技术一样,机器人肺叶切除术后可能会出现术后疼痛。椎旁阻滞可有助于减轻术后疼痛以及吗啡和镇痛药物的使用,并改善早期活动。